Liver Cancer: Symptoms, Causes, Diagnosis & Treatment

 The liver does its job quietly. It filters the blood, breaks down food, removes toxins, makes proteins, and keeps dozens of body functions running. Most people never think about it until something goes wrong.

Liver cancer is one of the most serious things that can go wrong and one of the most dangerous, precisely because it gives very little warning in its early stages. By the time symptoms appear, the cancer has often already grown significantly.

But for people who know their risk, screening changes everything. Liver tumours found early through a routine ultrasound are in a completely different treatment category from those found because a patient felt sick.

Liver Cancer in India What the Numbers Tell Us

This is not just a global problem. India carries a significant share of it.

According to the Global Burden of Disease data and ICMR registry records, liver cancer incidence in India is rising. The age-adjusted incidence rate of hepatocellular carcinoma ranges from 1 to 7.5 per 100,000 population with men affected nearly four times more than women. Northeastern states like Sikkim and Arunachal Pradesh report some of the highest liver cancer rates in the country.

And the burden is shifting. For years, hepatitis B and C were the dominant causes of liver cancer in India. That is changing. A major multicentric Indian study found that NAFLD non-alcoholic fatty liver disease is now the most common cause of HCC in India at 35.5%, followed by hepatitis B at 21.2%, hepatitis C at 18%, and alcohol at 13.9%.

What this means in plain terms: liver cancer in India is no longer just a disease of people with viral hepatitis. Rising obesity, diabetes, and metabolic disease are creating a new wave of liver cancer in people who have never had hepatitis at all.

India has approximately 29.8 million people living with chronic hepatitis B infection one of the largest burdens in the world. HBV alone caused an estimated 98,305 deaths in India in 2022. Each one of those people is at elevated risk of developing liver cancer without knowing it.

Liver cancer kills most people it reaches because it is usually found late. In India, where screening uptake is low and awareness is limited, most cases are discovered at a stage where curative treatment is no longer possible.

That is what screening exists to change.

What is Liver Cancer?

Liver cancer starts when cells in the liver begin growing in an abnormal way and form a tumour. The most common type is hepatocellular carcinoma HCC liver cancer which begins in the main liver cells called hepatocytes.

Primary liver cancer starts in the liver itself. Metastatic liver cancer also called secondary liver cancer has spread to the liver from another organ, such as the colon, breast, or lungs. These are different diseases that are managed differently.

What Does the Liver Do?

Understanding why liver cancer is so serious starts with understanding what the liver does. It digests fats, removes toxins from the blood, stores nutrients and energy, produces proteins the body needs for clotting and immune function, and regulates metabolism. When cancer disrupts the liver, all of these functions are affected which is why liver cancer complications can be so severe.

Types of Liver Cancer

Hepatocellular carcinoma (HCC) The most common type accounts for around 75-85% of all primary liver cancer cases. Almost always develops on a background of chronic liver disease.

Cholangiocarcinoma Cancer that develops in the bile ducts the small tubes that carry bile from the liver. Less common than HCC and treated differently.

Hepatoblastoma A rare liver cancer that mainly affects young children. Very different biology from adult liver cancer.

Angiosarcoma An extremely rare cancer affecting the blood vessels inside the liver.

Early Signs of Liver Cancer

Liver cancer in its early stages usually causes no symptoms at all. This is exactly what makes it dangerous and exactly why screening matters for people at risk.

When symptoms do appear, they are often signs that the cancer has been growing for some time:

• Upper abdominal pain — a dull ache or pressure in the upper right side of the abdomen, where the liver sits
• Jaundice — yellowing of the skin and eyes when the liver can no longer process bilirubin properly. Yellow skin and eyes that appear without an obvious cause need prompt investigation
• Unexplained weight loss — losing weight without changing diet or activity
• Loss of appetite — not wanting to eat, feeling full after very small amounts of food
• Nausea and vomiting — particularly when combined with other symptoms listed here
• Swollen abdomen and ascites — fluid building up inside the abdomen, causing visible swelling and a heavy feeling
• Fatigue and weakness — persistent tiredness that doesn’t improve with rest
• Itchy skin — from bile salts building up when bile flow is disrupted

None of these symptoms alone confirms liver cancer. But any of them in a person with known liver disease needs medical evaluation without delay.

What Causes Liver Cancer?

Liver cancer almost always develops on a background of existing liver damage. The most important causes and risk factors:

Hepatitis B and liver cancer Chronic hepatitis B is the leading cause of liver cancer globally and particularly in India. Long-term HBV infection causes chronic inflammation that drives cirrhosis and eventually HCC. This is why hepatitis B vaccination is one of the most effective liver cancer prevention strategies available.

Hepatitis C and liver cancer Chronic hepatitis C infection causes progressive liver scarring. Unlike hepatitis B, hepatitis C is now curable antiviral treatment that clears the virus significantly reduces liver cancer risk.

Cirrhosis and liver cancer Any cause of cirrhosis  the end-stage scarring of the liver raises liver cancer risk substantially. People with cirrhosis from any cause need regular liver cancer screening.

Fatty liver disease and liver cancer NAFLD and liver cancer Non-alcoholic fatty liver disease is increasingly recognised as a pathway to liver cancer, particularly when it progresses to NASH and cirrhosis. Obesity and liver cancer and diabetes and liver cancer risk are both closely linked through NAFLD.

Alcohol and liver cancer Heavy, long-term alcohol use causes cirrhosis which then increases liver cancer risk. Alcohol doesn’t directly cause HCC as frequently as hepatitis does, but through its effect on the liver it is a significant risk factor.

Aflatoxin exposure Aflatoxins are toxins produced by moulds that grow on stored grains and groundnuts in warm, humid conditions. Consuming food contaminated with aflatoxin is a liver cancer risk factor, particularly in parts of India and Africa.

Obesity, diabetes, and metabolic disease Both drive NAFLD progression and create an inflammatory liver environment that increases cancer risk over time.

Liver Cancer Screening: Who Should Get Tested and When

Screening for liver cancer is recommended for high-risk individuals those with cirrhosis from any cause, or chronic hepatitis B even without cirrhosis.

Abdominal ultrasound for liver cancer The standard screening tool. An ultrasound every six months is recommended for high-risk individuals. It uses sound waves to create images of the liver and can detect liver tumours before they cause any symptoms.

AFP blood test and alpha-fetoprotein test Alpha-fetoprotein is a protein that is often elevated in people with liver cancer. Used alongside ultrasound — not as a standalone test, because AFP levels can also rise in hepatitis and other conditions. A rising AFP in someone with liver disease needs further investigation even if the ultrasound looks normal.

CT scan for liver cancer and MRI for liver cancer When ultrasound finds something abnormal, CT or MRI provides detailed images that characterise the lesion its size, its blood supply pattern, and whether it looks like HCC or something else.

PET CT scan Used in selected cases to assess spread to other parts of the body lymph nodes, lungs, or bones.

Liver biopsy In most cases, liver cancer can be diagnosed from imaging alone without a biopsy a pattern of blood vessel enhancement on CT or MRI is highly specific for HCC. Biopsy is done when imaging is inconclusive or when the diagnosis will significantly change management.

Stages of Liver Cancer

Liver cancer staging is used to decide on treatment. The Barcelona Clinic Liver Cancer (BCLC) system is most widely used:

Stage A — Early liver cancer Single small tumour or up to three small tumours, good liver function, no symptoms. Surgery, ablation, or transplantation may be curative.

Stage B — Intermediate liver cancer Multiple tumours but still contained within the liver. Liver function still reasonable. Chemoembolization is typically the treatment.

Stage C — Advanced liver cancer Cancer has spread into blood vessels or to nearby tissues. Targeted therapy and immunotherapy are the main options.

Stage D — End-stage liver cancer Liver function severely impaired, advanced cancer. Treatment is palliative focused on comfort and quality of life.

Liver Cancer Prognosis The Honest Picture

This is what most people and families want to know after a diagnosis. So here it is, plainly.

Prognosis in liver cancer depends on two things more than anything else the stage at diagnosis and how much underlying liver disease is already present.

Stage-wise prognosis BCLC system:

The India reality:

Most liver cancer cases in India are discovered at Stage C or D advanced or end-stage. This is the core problem. The 5-year survival rate for all liver cancer cases combined in India sits below 15% not because treatment is inadequate, but because early-stage cases are the minority.

When liver cancer is found at Stage A through regular screening, the numbers change dramatically. Surgical resection of a small, solitary HCC gives 5-year survival rates of 50–70%. Liver transplantation for eligible patients gives 5-year survival above 70% in carefully selected cases.

The one thing that changes prognosis:

Cirrhosis patients and chronic hepatitis B carriers who get their six-monthly ultrasound consistently these are the people who get found at Stage A. That ultrasound, every six months, is the difference between a curable cancer and an incurable one.

No drug, no treatment, no technology changes prognosis as reliably as early detection does.

Complications of Liver Cancer What Happens When It Advances

Liver cancer does not stay contained. As it grows or when it is left untreated it creates specific, serious complications that affect quality of life significantly.

Ascites

Fluid builds up in the abdominal cavity, causing visible swelling, heaviness, and discomfort. As cancer disrupts liver function and portal blood flow, the body retains fluid. Ascites is one of the most common and distressing complications of advanced liver cancer. It requires drainage and ongoing management.

Portal hypertension and variceal bleeding

When cancer or cirrhosis raises pressure in the portal vein the large vein supplying the liver blood is forced into smaller vessels that are not designed to handle it. These vessels, called varices, can rupture and bleed internally. Upper gastrointestinal bleeding from varices is a medical emergency.

Jaundice

When the tumour presses on or invades the bile ducts, bile cannot flow properly and backs up into the bloodstream. This causes yellowing of the skin and eyes, dark urine, pale stools, and severe itching. Progressive jaundice is a sign that liver function is being significantly disrupted.

Hepatic encephalopathy

A failing liver cannot remove toxins particularly ammonia from the blood. These toxins reach the brain and cause confusion, memory problems, personality changes, and in severe cases, loss of consciousness. This is called hepatic encephalopathy and requires urgent medical management.

Hepatorenal syndrome

Advanced liver cancer and cirrhosis can cause the kidneys to fail not because of a direct kidney problem, but because of the severe disruption to blood flow caused by liver disease. This is called hepatorenal syndrome and significantly worsens prognosis.

Spread to other organs metastasis

HCC can spread to the lungs, bones, adrenal glands, and lymph nodes. Once liver cancer has metastasised, treatment shifts from curative intent to disease control and quality of life management.

These complications underscore one essential point liver cancer caught at Stage A, before any of this has happened, is an entirely different disease from liver cancer found after complications develop. Screening is what makes that difference.

Liver Cancer Treatment

Liver resection surgery and partial hepatectomy

Surgical removal of the part of the liver containing the tumour. Only possible when liver function is good enough and enough healthy liver will remain after surgery. The liver can partially regenerate after resection a remarkable feature that makes this surgery possible.

Liver transplantation

When a patient has early-stage HCC and underlying cirrhosis that has damaged too much of the liver for resection, transplantation removes both the cancer and the diseased liver in one procedure. Governed by strict criteria tumour size and number to ensure good outcomes.

Radiofrequency ablation (RFA treatment)

Heat generated by radio waves is delivered directly into the tumour through a needle guided by ultrasound or CT. Kills cancer cells without surgery. Highly effective for small tumours. One of the most commonly used treatments for early HCC when surgery isn’t suitable.

Chemoembolization

A procedure that delivers chemotherapy drugs directly into the blood vessels supplying the tumour and then blocks those vessels to cut off the tumour’s blood supply. Used for intermediate-stage liver cancer where ablation or surgery isn’t possible.

Targeted therapy for liver cancer

Drugs like sorafenib and lenvatinib target the molecular pathways that drive HCC growth. Used in advanced liver cancer where local treatments are no longer sufficient.

Immunotherapy for liver cancer

Checkpoint inhibitors atezolizumab combined with bevacizumab is now a first-line option for advanced HCC help the immune system identify and attack cancer cells. Outcomes with this combination have been meaningfully better than targeted therapy alone.

Palliative care for liver cancer

For end-stage disease, palliative care manages pain, ascites, fatigue, and other symptoms while maintaining the best possible quality of life. It is not giving up it is specialised care for a specific and difficult situation.

Radioembolization TARE

Radioembolization also called TARE (Transarterial Radioembolization) is a procedure that delivers tiny radioactive beads directly into the blood vessels feeding the tumour. The beads both block the tumour’s blood supply and deliver targeted radiation from inside. Used for intermediate and some advanced-stage HCC when chemoembolization is not suitable or has stopped working. Available at select liver cancer centres in India.

Percutaneous Ethanol Injection (PEI)

A needle is guided by ultrasound directly into small liver tumours, and pure alcohol is injected into the tumour. The alcohol kills cancer cells by dehydrating them. Used for very small HCC tumours particularly in patients who are not suitable for surgery or radiofrequency ablation. Simpler and less expensive than RFA, though generally considered slightly less effective for larger tumours. Still used in resource-limited settings and for tumours in specific locations where RFA is technically difficult.

What to Expect During Treatment Side Effects Patients Should Know

Treatment decisions are easier when patients know what to expect. Here is an honest overview.

After liver resection surgery

Hospital stay of 5–10 days is typical. Fatigue for several weeks after. The liver regenerates this is one of its remarkable properties but full recovery takes time. Patients need regular follow-up scans for monitoring. Temporary bile leak or bleeding are known surgical risks that the team monitors for closely.

After liver transplantation

Lifelong immunosuppressant medications are needed to prevent rejection. These reduce immunity, making infections a more serious concern. Regular monitoring of liver function, drug levels, and cancer recurrence is essential long-term. Transplant patients need close follow-up for life but for those who are eligible, it offers the best chance of cure combined with treatment of the underlying liver disease.

Radiofrequency ablation (RFA) recovery

Generally well-tolerated. Mild pain and fever in the first 48 hours are common this is a normal post-ablation response called post-ablation syndrome. Most patients go home within 1–2 days. Follow-up imaging in 4–6 weeks confirms whether the tumour has been fully treated.

Chemoembolization (TACE) side effects

Post-embolization syndrome pain, fever, nausea lasting 3–7 days is very common after TACE. This is expected and managed with medication. Liver function can temporarily worsen. Blood tests are monitored closely in the weeks following the procedure.

Targeted therapy side effects

Sorafenib and lenvatinib commonly cause fatigue, diarrhoea, high blood pressure, hand-foot skin reaction a painful redness and peeling of palms and soles and loss of appetite. These are manageable with dose adjustments and supportive care but can affect quality of life significantly in some patients.

Immunotherapy side effects

The atezolizumab-bevacizumab combination can cause immune-related side effects the immune system attacking healthy organs including the liver, lungs, or skin. Fatigue, elevated liver enzymes, and bleeding risk from bevacizumab are the most common concerns. Any new symptom during immunotherapy should be reported to the treating team promptly.

How to Reduce Liver Cancer Risk

• Hepatitis B vaccination highly effective. All newborns should receive it. Unvaccinated adults at risk should get it
• Get tested for hepatitis C it’s now curable with modern antivirals
• Limit alcohol or stop entirely if liver disease is already present
• Maintain a healthy weight reduces NAFLD progression
• Manage diabetes with proper medical support
• Avoid aflatoxin-contaminated food store grains and groundnuts properly
• If you have cirrhosis or chronic hepatitis B get your six-monthly ultrasound. Every time

Liver Cancer Myths — Busted

“Liver cancer only happens to people who drink heavily.” Alcohol is one cause — but hepatitis B and C, NAFLD, diabetes, and obesity are equally or more important in most populations. Many people with liver cancer have never drunk heavily.

“If I feel fine, my liver is fine.” Early liver cancer causes no symptoms. Feeling fine means nothing when it comes to liver cancer risk. The entire point of screening is to find problems before they cause symptoms.

“Liver cancer can’t be treated.” Early-stage liver cancer found through screening — can be cured with surgery, transplantation, or ablation. Even advanced liver cancer now has meaningful treatment options with modern targeted and immunotherapy.

When Should You See a Doctor?

See a hepatologist or oncologist promptly if you have:

• Jaundice yellow skin and eyes without an obvious cause
• Unexplained weight loss alongside loss of appetite
• Swollen abdomen or signs of ascites
• Upper abdominal pain that persists
• Persistent fatigue and weakness in someone with known liver disease

And if you have cirrhosis, chronic hepatitis B, or chronic hepatitis C make sure you are on a regular six-monthly ultrasound programme. This is not optional. It’s the intervention that catches liver cancer when it can still be treated.

Book an online liver cancer consultation or hepatologist consultation through HealthPil for screening guidance, AFP test interpretation, second opinions, and treatment planning from home, without a long wait.

How HealthPil Can Help

HealthPil connects you with experienced hepatologists and oncologists who manage liver cancer regularly from screening and early diagnosis through treatment planning, transplant evaluation, and palliative care. Whether you need a first opinion, a second opinion, or ongoing guidance, the right specialist is available through an online consultation.

Summary

Liver cancer develops silently usually found late unless high-risk individuals are screened regularly. Main causes: hepatitis B, hepatitis C, cirrhosis, NAFLD, alcohol, obesity, and aflatoxin exposure. Warning signs include jaundice, upper abdominal pain, unexplained weight loss, ascites, and fatigue.

Six-monthly ultrasound and AFP testing is recommended for anyone with cirrhosis or chronic hepatitis B. Treatment depends on stage surgery, transplant, RFA, chemoembolization, TARE, targeted therapy, or immunotherapy. Hepatitis B vaccination remains the single most effective prevention tool available.

Stage A liver cancer is curable. Stage D is not. That difference comes down entirely to when it was found.